ANZBCTG Oncology Conference Review - reviewed by Dr Richard Isaacs

In this issue:

Decision Aid improves trial participation
New Zealand exposure to Lapatinib
Later hormonal ‘adjuvant’ therapy for early breast cancer
PARP inhibitors show much potential
Adjuvant Trastuzumab trial update
Trastuzumab may have wider benefits
Capecitabine – a survival advantage?
Improving gene expression assay accuracy
Identifying new genes for breast cancer
Issues surrounding hypofractionation of radiotherapy

Download PDF Subscribe